A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B‐cell non‐Hodgkin lymphoma: A Wisconsin Oncology Network study by Fenske, Timothy S., Shah, Namrata M., Kim, Kyung Mann, Saha, Sandeep, Zhang, Chong, Baim, Arielle E., Farnen, John P., Onitilo, Adedayo A., Blank, Jules H., Ahuja, Harish, Wassenaar, Tim, Qamar, Rubina, Mansky, Patrick, Traynor, Anne M., Mattison, Ryan J., Kahl, Brad S.

Get full text

First Results of Asciminib As Initial Therapy with Addition of Lower Dose Tyrosine Kinase Inhibitors for Patients with Chronic Myeloid Leukemia Who Do Not Achieve a Deep Molecular... by Cortes, Jorge E., Mauro, Michael J., Visotcky, Alexis, Tantravahi, Srinivas K, Thompson, James E, Yang, Jay, Baim, Arielle, Gao, Yan, Maldonado-Schmidt, Sonia, Olig, Claire, Flynn, Kathryn E., Radich, Jerald P., Atallah, Ehab L.

Get full text

Treatment Free Remission after Combination Therapy with Asciminib (ABL001) Plus Imatinib in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed after a Prior Atte... by Mauro, Michael, Visotcky, Alexis, Flynn, Kathryn E, Radich, Jerald P., Yang, Jay, Oehler, Vivian G., Cortes, Jorge E., Kota, Vamsi K, Tantravahi, Srinivas K., Baim, Arielle, Zhang, Mei-Jie, Hinman, Alexander, Atallah, Ehab L., Sweet, Kendra

Get full text

HJKC3-007: Outcomes of Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Asciminib and Other Tyrosine Kinase Inhibitors in Routine Clinical Practice by Mauro, Michael, Atallah, Ehab L., Thompson, James E, Gao, Yan, Visotcky, Alexis, Giever, Emily, Baim, Arielle, Akinola, Idayat, Larson, Richard A., Jamy, Omer, Cortes, Jorge, Druker, Brian J., Shah, Neil P., Pinilla-Ibarz, Javier, Yang, Jay, Ritchie, Ellen K., Rein, Lindsay A.M, Tantravahi, Srinivas K., Badar, Talha, Smith, B. Douglas, Deininger, Michael W., Flynn, Kathryn E

Get full text

HJKC3-0006: Outcome of Patients with CML Treated on Second Line or Later Therapy in Routine Clinical Practice by Thompson, James E, Gao, Yan, Visotcky, Alexis, Flynn, Kathryn E, Mauro, Michael, Giever, Emily, Baim, Arielle, Akinola, Idayat, Larson, Richard, Jamy, Omer, Hunter, Anthony M., Kota, Vamsi K., Cortes, Jorge, Druker, Brian J., Shah, Neil P., Pinilla-Ibarz, Javier, Yang, Jay, Ritchie, Ellen K., Rein, Lindsay A.M, Smith, B. Douglas, Tantravahi, Srinivas K., Badar, Talha, Deininger, Michael W., Atallah, Ehab L.

Get full text

Second Treatment Free Remission after Combination Therapy with Ruxolitinib Plus Tyrosine Kinase Inhibitors in Chronic Phase Chronic Myeloid Leukemia (CML) by Sweet, Kendra, Atallah, Ehab L., Radich, Jerry P., Zhang, Mei-Jie, Sahakian, Eva, Mediavilla-Varela, Melanie, Vistocky, Alexis, Heinrich, Michael C., Thompson, James E., Mauro, Michael J., Flynn, Kathryn E, Baim, Arielle, Pinilla Ibarz, Javier

Get full text

Asciminib As Initial Therapy for Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)-H. Jean Khoury Cure CML Consortium Study by Atallah, Ehab L., Visotcky, Alexis, Flynn, Kathryn E, Zhang, Mei-Jie, Radich, Jerald P., Yang, Jay, Oehler, Vivian G., Tantravahi, Srinivas K., Smith, B. Douglas Douglas, Pinilla Ibarz, Javier, Sweet, Kendra, Mauro, Michael, Druker, Brian J., Thompson, James E., Maldonado-Schmidt, Sonia, Baim, Arielle, Schiffer, Charles A., Kota, Vamsi K., Cortes, Jorge E.

Get full text

Building a National CML Registry by Atallah, Ehab L., Singavi, Arun K, Taylor, Bradley, Baim, Arielle, Myers, Judith, Giever, Emily, Neuner, Joan, Shaw, Bronwen E., Flynn, Kathryn E

Get full text

Molecular and Clinical Determinants of CAR-T Therapy Response in DLBCL by Thakkar, Devang, Hill, Brian T., Kositsky, Rachel, Tian, Shari, Biral, Leonardo, Russell, Veronica, Dave, Tushar, Love, Cassandra L., Roth, Caroline, McKinney, Matthew Stuart, Galal, Ahmed, Neff, Jadee, Mian, Agrima, Kendall, Ellen, Ondrejka, Sarah L., Chiaramonte, Matthew, Bhagat, Govind, Ofori, Kenneth N., Reshef, Ran, Kovach, Alexandra E., Sethi, Tarsheen, Mason, Emily F., Bhaskar, Shakthi, Oluwole, Olalekan O., McCall, Chad, Pallas, Christopher, Ghosh, Nilanjan, Ferdman, Robert, Chen, George, Hernandez-Ilizaliturri, Francisco, Zurko, Joanna, Cunningham, Ashley, Shah, Nirav C, Hu, Boyu, Stephens, Deborah M., Ghosh, Monalisa, Bailey, Neil, Patel, Krish, Pagel, John M., Kannan, Kavya Kannamma, Hsi, Eric D., Vaidya, Rakhee, Ip, Andrew, Goy, Andre, Kambhampati, Swetha, Ohgami, Robert, Andreadis, Charalambos, Gordillo, Christian A, Just, Brianna, Cohen, Jonathon B, Baim, Arielle, Barbello, Julie, Cavallone, Erika, Bachanova, Veronika, Laschen, Maureen, Teferra, Andinet, Lorcy, Frederique, Lamure, Sylvain, Cartron, Guillaume, Dardalhon, Valerie, Naresh, Kikkeri N, Czader, Magdalena, Reddy, Anupama, Thacker, Elizabeth, Parker, Clayton, Happ, Lanie, Dave, Sandeep

Get full text

Patients’ perspectives on the definition of cure in chronic myeloid leukemia by Flynn, Kathryn E., Mauro, Michael J., George, Gemlyn, Hinman, Alexander, Baim, Arielle, Kota, Vamsi, Larson, Richard A., Lipton, Jeffrey H., Thompson, James E., Wadleigh, Martha, Atallah, Ehab

Get full text

Patients' Perspectives on the Definition of Cure in Chronic Myeloid Leukemia: A US Based Survey by George, Gemlyn, Atallah, Ehab L., Mauro, Michael J., Goldberg, Stuart L., Baim, Arielle, Guhl, Jessica, Hinman, Alexander, Cortes, Jorge E., Deininger, Michael W., Druker, Brian J., Kota, Vamsi K, Larson, Richard A., Lipton, Jeffrey H., Moore, Joseph O., Oehler, Vivian G., Pinilla Ibarz, Javier, Radich, Jerald, Ritchie, Ellen K., Schiffer, Charles A., Shah, Neil P., Silver, Richard T., Sweet, Kendra L., Thompson, James E., Wadleigh, Martha, Flynn, Kathryn E

Get full text

Results from the U.S. Life after Stopping TKIs (LAST) Study by Atallah, Ehab, Schiffer, Charles A., Radich, Jerald P., Weinfurt, Kevin, Zhang, Mei-Jie, Kota, Vamsi, Pinilla-Ibarz, Javier, Moore, Joseph O., Larson, Richard A., Oehler, Vivian, Mauro, Michael J., Deininger, Michael W., Thompson, James E., Shah, Neil P., Wadleigh, Martha, Ritchie, Ellen K, Silver, Richard T, Cortes, Jorge E., Baim, Arielle, Horowitz, Mary M., Flynn, Kathryn

Get full text